• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱泼斯坦-巴尔病毒核抗原1的甘氨酸-丙氨酸重复结构域对泛素/蛋白酶体依赖性蛋白质降解的抑制作用

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

作者信息

Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci M G

机构信息

Microbiology and Tumor Biology Center, Karolinska Institute, Box 280, S-171 77 Stockholm, Sweden.

出版信息

Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12616-21. doi: 10.1073/pnas.94.23.12616.

DOI:10.1073/pnas.94.23.12616
PMID:9356498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC25057/
Abstract

The Epstein-Barr virus (EBV) encoded nuclear antigen (EBNA) 1 is expressed in latently infected B lymphocytes that persist for life in healthy virus carriers and is the only viral protein regularly detected in all EBV associated malignancies. The Gly-Ala repeat domain of EBNA1 was shown to inhibit in cis the presentation of major histocompatibility complex (MHC) class I restricted cytotoxic T cell epitopes from EBNA4. It appears that the majority of antigens presented via the MHC I pathway are subject to ATP-dependent ubiquitination and degradation by the proteasome. We have investigated the influence of the repeat on this process by comparing the degradation of EBNA1, EBNA4, and Gly-Ala containing EBNA4 chimeras in a cell-free system. EBNA4 was efficiently degraded in an ATP/ubiquitin/proteasome-dependent fashion whereas EBNA1 was resistant to degradation. Processing of EBNA1 was restored by deletion of the Gly-Ala domain whereas insertion of Gly-Ala repeats of various lengths and in different positions prevented the degradation of EBNA4 without appreciable effect on ubiquitination. Inhibition was also achieved by insertion of a Pro-Ala coding sequence. The results suggest that the repeat may affect MHC I restricted responses by inhibiting antigen processing via the ubiquitin/proteasome pathway. The presence of regularly interspersed Ala residues appears to be important for the effect.

摘要

爱泼斯坦-巴尔病毒(EBV)编码的核抗原(EBNA)1在潜伏感染的B淋巴细胞中表达,这些细胞在健康病毒携带者体内终生存在,并且是在所有EBV相关恶性肿瘤中经常检测到的唯一病毒蛋白。EBNA1的甘氨酸-丙氨酸重复结构域已被证明可顺式抑制主要组织相容性复合体(MHC)I类限制性细胞毒性T细胞表位从EBNA4的呈递。似乎通过MHC I途径呈递的大多数抗原都要经过蛋白酶体依赖ATP的泛素化和降解。我们通过在无细胞系统中比较EBNA1、EBNA4和含甘氨酸-丙氨酸的EBNA4嵌合体的降解情况,研究了该重复序列对这一过程的影响。EBNA4以ATP/泛素/蛋白酶体依赖的方式有效降解,而EBNA1对降解具有抗性。通过缺失甘氨酸-丙氨酸结构域可恢复EBNA1的加工过程,而在不同位置插入不同长度的甘氨酸-丙氨酸重复序列可阻止EBNA4的降解,而对泛素化没有明显影响。插入脯氨酸-丙氨酸编码序列也可实现抑制作用。结果表明,该重复序列可能通过抑制泛素/蛋白酶体途径的抗原加工来影响MHC I限制性反应。规则间隔的丙氨酸残基的存在似乎对该效应很重要。

相似文献

1
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.爱泼斯坦-巴尔病毒核抗原1的甘氨酸-丙氨酸重复结构域对泛素/蛋白酶体依赖性蛋白质降解的抑制作用
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12616-21. doi: 10.1073/pnas.94.23.12616.
2
Avoiding proteasomal processing: the case of EBNA1.避免蛋白酶体加工:EBNA1的情况。
Curr Top Microbiol Immunol. 2002;269:23-36. doi: 10.1007/978-3-642-59421-2_2.
3
Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.爱泼斯坦-巴尔病毒核抗原-1内部重复区域对抗原加工的抑制作用。
Nature. 1995 Jun 22;375(6533):685-8. doi: 10.1038/375685a0.
4
Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.将EBNA1靶向进行快速细胞内降解可克服甘氨酸-丙氨酸重复结构域的抑制作用,并恢复CD8+T细胞识别。
J Biol Chem. 2001 Sep 7;276(36):33353-60. doi: 10.1074/jbc.M104535200. Epub 2001 Jul 2.
5
Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.爱泼斯坦-巴尔病毒的甘氨酸-丙氨酸重复序列对蛋白酶体降解的抑制作用受重复序列长度和降解信号强度的影响。
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8381-5. doi: 10.1073/pnas.140217397.
6
Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.爱泼斯坦-巴尔病毒编码的EBNA1对合成及抗原呈递的自我抑制作用
Science. 2003 Sep 5;301(5638):1371-4. doi: 10.1126/science.1088902.
7
Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing.爱泼斯坦-巴尔病毒编码的核抗原1蛋白的重复序列会中断蛋白酶体底物的加工过程。
J Biol Chem. 2004 Mar 5;279(10):8635-41. doi: 10.1074/jbc.M310449200. Epub 2003 Dec 19.
8
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.爱泼斯坦-巴尔病毒潜伏膜蛋白1恢复伯基特淋巴瘤细胞内源性抗原加工:肽转运体和HLA-I类抗原表达的协同上调
Eur J Immunol. 1995 May;25(5):1374-84. doi: 10.1002/eji.1830250536.
9
Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.人类CD4(+) T淋巴细胞持续对潜伏的爱泼斯坦-巴尔病毒核抗原EBNA1产生反应。
J Exp Med. 2000 May 15;191(10):1649-60. doi: 10.1084/jem.191.10.1649.
10
cis-Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition.病毒重复序列对蛋白酶体降解的顺式抑制:长度和氨基酸组成的影响。
FEBS Lett. 2001 Jun 15;499(1-2):137-42. doi: 10.1016/s0014-5793(01)02542-x.

引用本文的文献

1
Model Systems of Gammaherpesvirus Infection, Immunity, and Disease.γ疱疹病毒感染、免疫与疾病的模型系统
J Med Virol. 2025 Sep;97(9):e70581. doi: 10.1002/jmv.70581.
2
Primary Sequence-Intrinsic Immune Evasion by Viral Proteins Guides CTL-Based Vaccine Strategies.病毒蛋白的一级序列固有免疫逃逸指导基于细胞毒性T淋巴细胞的疫苗策略。
Viruses. 2025 Jul 24;17(8):1035. doi: 10.3390/v17081035.
3
Amino acid insertion in the Meq protein of Marek's disease virus, an avian oncogenic herpesvirus, accelerates tumorigenesis.马立克氏病病毒(一种禽类致癌疱疹病毒)的Meq蛋白中的氨基酸插入会加速肿瘤发生。
Microbiol Spectr. 2025 Aug 5;13(8):e0336824. doi: 10.1128/spectrum.03368-24. Epub 2025 Jul 17.
4
Genetic evidence identifies a causal relationship between EBV infection and multiple myeloma risk.基因证据表明EB病毒感染与多发性骨髓瘤风险之间存在因果关系。
Sci Rep. 2025 Feb 21;15(1):6357. doi: 10.1038/s41598-025-90479-1.
5
Leveraging mRNA technology for antigen based immuno-oncology therapies.利用信使核糖核酸技术进行基于抗原的免疫肿瘤学治疗。
J Immunother Cancer. 2025 Jan 22;13(1):e010569. doi: 10.1136/jitc-2024-010569.
6
Epstein-Barr virus BALF0/1 subverts the Caveolin and ERAD pathways to target B cell receptor complexes for degradation.爱泼斯坦-巴尔病毒BALF0/1破坏小窝蛋白和内质网相关蛋白降解途径,以靶向降解B细胞受体复合物。
Proc Natl Acad Sci U S A. 2025 Jan 28;122(4):e2400167122. doi: 10.1073/pnas.2400167122. Epub 2025 Jan 23.
7
VZV IE4 downregulates cellular surface MHC-I via sequestering it to the Golgi complex.水痘带状疱疹病毒立即早期蛋白4通过将细胞表面主要组织相容性复合体I类分子隔离至高尔基体复合体来下调其表达。
Cell Mol Life Sci. 2024 Dec 27;82(1):23. doi: 10.1007/s00018-024-05477-9.
8
How Epstein Barr Virus Causes Lymphomas.爱泼斯坦-巴尔病毒如何导致淋巴瘤。
Viruses. 2024 Nov 6;16(11):1744. doi: 10.3390/v16111744.
9
Human Viral Oncoproteins and Ubiquitin-Proteasome System.人类病毒癌蛋白与泛素-蛋白酶体系统
Glob Med Genet. 2024 Sep 2;11(4):285-296. doi: 10.1055/s-0044-1790210. eCollection 2024 Dec.
10
Slippery sequences stall the 26S proteasome at multiple points along the translocation pathway.滑序列使 26S 蛋白酶体在易位途径的多个点停滞。
Protein Sci. 2024 Jun;33(6):e5034. doi: 10.1002/pro.5034.

本文引用的文献

1
The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis.重复DNA序列在爱泼斯坦-巴尔病毒(EBV)核抗原大小变异中的作用,以及使用限制性片段长度多态性(RFLP)和聚合酶链反应(PCR)分析鉴定不同的EBV分离株。
J Gen Virol. 1995 Apr;76 ( Pt 4):779-90. doi: 10.1099/0022-1317-76-4-779.
2
The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.蛋白酶体特异性抑制剂乳胞素可阻断人和鼠细胞中细胞毒性T淋巴细胞表位的呈递。
Eur J Immunol. 1997 Jan;27(1):336-41. doi: 10.1002/eji.1830270148.
3
Direct conversion of an oligopeptide from a beta-sheet to an alpha-helix: a model for amyloid formation.寡肽从β-折叠直接转变为α-螺旋:一种淀粉样蛋白形成模型。
Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):23-8. doi: 10.1073/pnas.94.1.23.
4
Epitope focusing in the primary cytotoxic T cell response to Epstein-Barr virus and its relationship to T cell memory.针对爱泼斯坦-巴尔病毒的原发性细胞毒性T细胞反应中的表位聚焦及其与T细胞记忆的关系。
J Exp Med. 1996 Nov 1;184(5):1801-13. doi: 10.1084/jem.184.5.1801.
5
Antigen processing and presentation by the class I major histocompatibility complex.由I类主要组织相容性复合体进行的抗原加工与呈递
Annu Rev Immunol. 1996;14:369-96. doi: 10.1146/annurev.immunol.14.1.369.
6
A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit.核因子-κB p105中富含甘氨酸的区域作为生成p50亚基的加工信号。
Mol Cell Biol. 1996 May;16(5):2248-54. doi: 10.1128/MCB.16.5.2248.
7
Silk properties determined by gland-specific expression of a spider fibroin gene family.蜘蛛丝蛋白基因家族腺体特异性表达决定的丝特性
Science. 1996 Apr 5;272(5258):112-5. doi: 10.1126/science.272.5258.112.
8
Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting.多聚泛素链的表面疏水残基对蛋白水解靶向至关重要。
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):861-6. doi: 10.1073/pnas.93.2.861.
9
Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis.酵母质膜受体的泛素化标志着其配体刺激的内吞作用。
Cell. 1996 Jan 26;84(2):277-87. doi: 10.1016/s0092-8674(00)80982-4.
10
Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.从健康血清阳性个体中分离出对爱泼斯坦-巴尔病毒核抗原1肽表位具有特异性的细胞毒性T淋巴细胞:对病毒持续存在和肿瘤监测的意义。
Virology. 1995 Dec 20;214(2):633-7. doi: 10.1006/viro.1995.0076.